[1] [2] Tirzepatide (Mounjaro for diabetes, Zepbound for weight management) is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, not a pure GLP-1 agonist
GLP-1 Tracking App FAQ Is there a free GLP-1 tracking app
Noom is basing its offering on a quarter dose of semaglutide 0.6mg per injection versus 2.4mg for Wegovy and said the rationale for the dose reduction comes from data gleaned from its members, as well as a couple of investigator-led studies published in The Lancet and New England Journal of Medicine
Best practice is a 4-week rotation cycle
JAMA Netw Open 7(3):e243604 [DOI] [PMC free article] [PubMed] [Google Scholar] 5.Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM et al (2022) Management of hyperglycaemia in type 2 diabetes, 2022